### ðŸ«  Valvular Heart Disease: Aortic Dissection and Acute Aortic Regurgitation

#### âœ… True Statements
1. **Transesophageal echocardiography (TEE)** is an appropriate diagnostic test for suspected **aortic dissection** with **aortic regurgitation**, especially in **unstable patients**.
2. **Acute aortic regurgitation** may be caused by **type A aortic dissection**, **endocarditis**, **blunt chest trauma**, or complications of **balloon valvuloplasty**.
3. In **acute aortic regurgitation**, murmurs may be **soft or short** due to **rapid pressure equalization** between the aorta and left ventricle.
4. **Bounding pulses** may not be present in acute aortic regurgitation because of **lack of increased stroke volume**.
5. **Abrupt volume overload** from acute aortic regurgitation may lead to **acute heart failure** or **cardiogenic shock**.
6. **Aortic dissection** involving the **aortic root** and causing **acute aortic regurgitation** constitutes a **surgical emergency**.
7. **Computed tomography angiography (CTA)** is widely used in suspected aortic dissection and can inform **procedural planning**.
8. **TEE** provides added detail in evaluating **aortic valve structure and function** and is portable for unstable patients.
9. **Magnetic resonance angiography (MRA)** is rarely used in the **acute setting** of aortic dissection due to **prolonged scan times** and **limited emergency availability**.
10. **V/Q scanning** is primarily used to diagnose **pulmonary embolism**, not aortic dissection.

#### ðŸ’¬ Extra
1. TEE allows diagnosis of both aortic dissection and aortic regurgitation without needing contrast or transporting unstable patients.
3. Short murmurs may be misinterpreted or missed on auscultation, especially in critical illness.
4. This contrasts with **chronic aortic regurgitation**, where bounding pulses are more likely due to long-standing volume overload.
6. Involvement of the **aortic root** increases risk for pericardial tamponade and requires **urgent surgical intervention**.

#### ðŸ”· Tags
#Cardiology #ValvularHeartDisease #AorticRegurgitation #AorticDissection #TEE #CTAngiography #EmergentCare

#### ðŸ“™ Reference
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. *Circulation*. 2020:CIR0000000000000923. PMID: 33332150 doi:10.1161/CIR.0000000000000923

#### ðŸ†” Question ID
CVMCQ24127

#### ðŸ•’ Last Updated
January 2025

---

#### ðŸ“– Related Text
MKSAP 19: Cardiovascular Medicine â€” Valvular Heart Disease, Aortic Regurgitation

---

### ðŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Aortic regurgitation** may result from **aortic root pathology** or **intrinsic valve disease**.
2. Causes of **acute aortic regurgitation** include **aortic dissection**, **endocarditis**, **blunt chest trauma**, and **iatrogenic damage**.
3. In **chronic aortic regurgitation**, **volume overload** leads to **left ventricular (LV) dilatation** and **eccentric hypertrophy**.
4. Clinical findings of **chronic aortic regurgitation** include **bounding peripheral pulses**, **displacement of the LV apex**, and a **diastolic decrescendo murmur**.
5. The murmur of chronic aortic regurgitation may be heard along the **right sternal border** (aortic root pathology) or **left sternal border** (valve pathology).
6. In **acute aortic regurgitation**, murmurs may be **soft or short**, and **bounding pulses may be absent**.
7. **Transthoracic echocardiography (TTE)** is indicated for evaluation of **aortic regurgitation** and **LV function**.
8. When **TTE images are suboptimal** or findings are **discordant with clinical suspicion**, additional testing with **TEE**, **cardiac magnetic resonance (CMR)**, or **cardiac catheterization** is indicated.
9. **CT angiography** is indicated in patients with **acute aortic regurgitation and aortic dissection** due to its **accuracy and rapid availability**.
10. Severe aortic regurgitation is defined by a **regurgitant jet width â‰¥65%** of the **LV outflow tract**, **vena contracta >0.6 cm**, **regurgitant volume â‰¥60 mL**, or **effective regurgitant orifice area â‰¥0.3 cmÂ²**.

#### ðŸ’¬ Extra
1. Common root causes include **ascending aortic dilatation** and **bicuspid valve disease**.
4. These features reflect the hemodynamic burden and structural remodeling over time.
6. Rapid hemodynamic shifts explain the subtler findings compared to chronic regurgitation.
10. These echocardiographic parameters help quantify severity and guide intervention.

#### ðŸ”· Tags
#Cardiology #ValvularHeartDisease #AorticRegurgitation #AorticDissection #Echocardiography #CTAngiography #CMR

---

#### ðŸŽ¥ Supplemental Video

<figure>
  <video controls src="Chronic Aortic Regurgitation.mp4" width="100%"></video>
  <figcaption>
    <strong>Chronic Aortic Regurgitation</strong><br>
    The carotid pulse is bisferiens with a brisk upstroke. In the aortic area, there is a high-frequency grade 2, diastolic decrescendo murmur. The murmur begins with A2 and then diminishes in intensity.<br>
    Video used with permission from the Michael S. Gordon Center for Simulation and Innovation in Medical Education, University of Miami Miller School of Medicine, Miami, Florida. <a href="https://gordoncenter.miami.edu" target="_blank">https://gordoncenter.miami.edu</a>
  </figcaption>
</figure>

---

### ðŸ“Š Supplemental Table

<table>
  <caption><strong>Serial Evaluation of Asymptomatic Patients With Left-Sided Valvular Conditions</strong></caption>
  <thead>
    <tr>
      <th>Condition</th>
      <th>Factors Considered</th>
      <th>VHD Stage</th>
      <th>Lesion Severity</th>
      <th>Frequency of Evaluation</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td rowspan="4"><strong>Aortic Stenosis</strong></td>
      <td rowspan="4">Stenosis severity; rate of progression; LV systolic function; ascending aorta dilation if associated with bicuspid aortic valve</td>
      <td>A</td>
      <td>At risk (V<sub>max</sub> &lt;2 m/s)</td>
      <td>â€”</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Mild (V<sub>max</sub> 2.0â€“2.9 m/s or mean gradient &lt;20 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 3â€“5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (V<sub>max</sub> 3.0â€“3.9 m/s or mean gradient 20â€“39 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 1â€“2 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (V<sub>max</sub> â‰¥4 m/s or mean gradient â‰¥40 mm Hg, AVA typically â‰¤1.0 cmÂ²)<br>Very severe (V<sub>max</sub> â‰¥5 m/s or mean gradient â‰¥60 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 6â€“12 mo</td>
    </tr>
    <tr>
      <td rowspan="3"><strong>Aortic Regurgitation</strong></td>
      <td rowspan="3">Regurgitation severity; rate of progression; LV ejection fraction; LV chamber size; ascending aorta dilation if bicuspid aortic valve</td>
      <td>B</td>
      <td>Mild (VC &lt;0.3 cm, ERO &lt;0.10 cmÂ², RV &lt;30 mL/beat, RF &lt;30%); normal EF</td>
      <td>Clinical evaluation yearly; echo every 3â€“5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (VC 0.3â€“0.6 cm, ERO 0.10â€“0.29 cmÂ², RV 30â€“59 mL/beat, RF 30%â€“49%)</td>
      <td>Clinical evaluation yearly; echo every 1â€“2 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (VC &gt;0.6 cm, ERO â‰¥0.3 cmÂ², RV â‰¥60 mL/beat, RF â‰¥50%)</td>
      <td>Clinical evaluation every 6â€“12 mo; echo every 6â€“12 mo, more frequently for dilating LV</td>
    </tr>
    <tr>
      <td rowspan="2"><strong>Mitral Stenosis</strong></td>
      <td rowspan="2">Stenosis severity</td>
      <td>B</td>
      <td>Mild and moderate (MVA &gt;1.5 cmÂ², diastolic pressure half-time &lt;150 ms)</td>
      <td>Clinical evaluation yearly; echo every 3â€“5 y</td>
    </tr>
    <tr>
      <td>C1</td>
      <td>Severe (MVA 1.0â€“1.5 cmÂ², diastolic pressure half-time â‰¥150 ms or â‰¥220 ms with very severe stenosis, PASP &gt;50 mm Hg)</td>
      <td>Clinical evaluation yearly; echo every 1â€“2 y for MVA 1.0â€“1.5 cmÂ², every year for MVA &lt;1.0 cmÂ²</td>
    </tr>
    <tr>
      <td rowspan="3"><strong>Mitral Regurgitation</strong></td>
      <td rowspan="3">Regurgitation severity; rate of progression; EF; LV chamber size</td>
      <td>A</td>
      <td>Mild (VC &lt;0.3 cm, ERO &lt;0.2 cmÂ², RV &lt;30 mL/beat, RF &lt;30%)</td>
      <td>Clinical evaluation yearly; echo every 3â€“5 y</td>
    </tr>
    <tr>
      <td>B</td>
      <td>Moderate (VC &lt;0.7 cm, ERO 0.2â€“0.39 cmÂ², RV 30â€“59 mL/beat, RF 30%â€“49%)</td>
      <td>Clinical evaluation yearly; echo every 1â€“2 y</td>
    </tr>
    <tr>
      <td>C</td>
      <td>Severe (VC â‰¥0.7 cm, ERO â‰¥0.4 cmÂ², RV â‰¥60 mL/beat, RF â‰¥50%)</td>
      <td>Clinical evaluation every 6â€“12 mo; echo every 6â€“12 mo, more frequently for dilating LV</td>
    </tr>
  </tbody>
</table>

<p><em>
AVA = aortic valve area; echo = echocardiography; EF = ejection fraction; ERO = effective regurgitant orifice; LV = left ventricular; LVESD = left ventricular end-systolic dimension; MVA = mitral valve area; PASP = pulmonary artery systolic pressure; RF = regurgitant fraction; RV = regurgitant volume; VC = vena contracta width; VHD = valvular heart disease; V<sub>max</sub> = maximum aortic jet velocity.
</em></p>

<p><strong>Reference:</strong> Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2021;77:e25â€“e197. <a href="https://doi.org/10.1016/j.jacc.2020.11.018">doi:10.1016/j.jacc.2020.11.018</a> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33342586">33342586</a>
</p>